A twice-weekly split keeps the full therapeutic dose
There simply hasnt been enough time to gather the kind of comprehensive, multi-generational pregnancy outcome data that exists for older medications
Research from the STEP trials (semaglutide) and SURMOUNT-4 (tirzepatide) shows that without ongoing pharmacotherapy or substantial behavioral interventions, significant weight regain occurs within the first year after stopping treatment
Greater understanding of trial generalizability is needed. In the cross-sectional study, the researchers examined a cohort of 8,767 participants aged 20 years or older from the National Health and Nutrition Examination Survey to determine proportions of those who were met the FDAs label criteria for weight loss treatment and those who met trial exclusion criteria
Consequently, the primary targets of insulins action are the liver, muscles, and adipose tissue, which are tailored for energy storage
Thats according to a small clinical trial run by Novo Nordisk, so real-life results may vary
.png)
